Literature DB >> 10339027

Cholesterol and coronary heart disease: screening and treatment.

S Ebrahim1, G D Smith, C McCabe, N Payne, M Pickin, T A Sheldon, F Lampe, F Sampson, S Ward, G Wannamthee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10339027      PMCID： PMC2483615          DOI： 10.1136/qshc.7.4.232

Source DB:  PubMed          Journal:  Qual Health Care        ISSN： 0963-8172


× No keyword cloud information.
  61 in total

1.  Drug treatment of hypertension in the elderly: a meta-analysis.

Authors:  J T Insua; H S Sacks; T S Lau; J Lau; D Reitman; D Pagano; T C Chalmers
Journal:  Ann Intern Med       Date:  1994-09-01       Impact factor: 25.391

2.  Near patient testing in general practice: attitudes of general practitioners and practice nurses, and quality assurance procedures carried out.

Authors:  S Hilton; E Rink; J Fletcher; B Sibbald; P Freeling; A Szczepura; C Davies; J Stilwell
Journal:  Br J Gen Pract       Date:  1994-12       Impact factor: 5.386

Review 3.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.

Authors:  R Collins; S MacMahon
Journal:  Br Med Bull       Date:  1994-04       Impact factor: 4.291

4.  Eight compact analysis systems evaluated for measuring total cholesterol.

Authors:  L C Gregory; S H Duh; R H Christenson
Journal:  Clin Chem       Date:  1994-04       Impact factor: 8.327

5.  Is knowing your cholesterol number harmful?

Authors:  M J Irvine; A G Logan
Journal:  J Clin Epidemiol       Date:  1994-02       Impact factor: 6.437

6.  Meta-analysis of the effects of soy protein intake on serum lipids.

Authors:  J W Anderson; B M Johnstone; M E Cook-Newell
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

Review 7.  An analysis of the effectiveness of interventions intended to help people stop smoking.

Authors:  M Law; J L Tang
Journal:  Arch Intern Med       Date:  1995-10-09

8.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.

Authors:  M de Lorgeril; S Renaud; N Mamelle; P Salen; J L Martin; I Monjaud; J Guidollet; P Touboul; J Delaye
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

9.  Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration.

Authors:  P J Elton; A Ryman; M Hammer; F Page
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

10.  Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants.

Authors:  H A Neil; L Roe; R J Godlee; J W Moore; G M Clark; J Brown; M Thorogood; I M Stratton; T Lancaster; D Mant
Journal:  BMJ       Date:  1995-03-04
View more
  5 in total

Review 1.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Kirsten Ward; Theresa Hm Moore; Margaret Burke; George Davey Smith; Juan-Pablo Casas; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

Review 2.  Dietary fat intake and prevention of cardiovascular disease: systematic review.

Authors:  L Hooper; C D Summerbell; J P Higgins; R L Thompson; N E Capps; G D Smith; R A Riemersma; S Ebrahim
Journal:  BMJ       Date:  2001-03-31

Review 3.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

4.  How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England.

Authors:  Paul R Ward; Peter R Noyce; Antony S St Leger
Journal:  Int J Equity Health       Date:  2007-03-27

5.  Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.

Authors:  Paul R Ward; Peter R Noyce; Antony S St Leger
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.